Hypertension guidelines: thresholds, targets, and teratogenicity

Hypertension guidelines: thresholds, targets, and teratogenicity.

Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets?

Since 1966, a large number of trials of blood pressure (BP) lowering drugs compared with placebo (or no treatment) in hypertensive patients, complemented by trials of more versus less intense BP lowering, have shown that antihypertensive treatment can significantly reduce the incidence of fatal and nonfatal events associated with hypertension. A meta-analysis of all BP-lowering trials from 1966...

Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets?

Since 1966, a large number of trials of blood pressure (BP) lowering drugs compared with placebo (or no treatment) in hypertensive patients, complemented by trials of more versus less intense BP lowering, have shown that antihypertensive treatment can significantly reduce the incidence of fatal and nonfatal events associated with hypertension. A meta-analysis of all BP-lowering trials from 1966...

Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets?

Since 1966, a large number of trials of blood pressure (BP) lowering drugs compared with placebo (or no treatment) in hypertensive patients, complemented by trials of more versus less intense BP lowering, have shown that antihypertensive treatment can significantly reduce the incidence of fatal and nonfatal events associated with hypertension. A meta-analysis of all BP-lowering trials from 1966...

Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets?

Since 1966, a large number of trials of blood pressure (BP) lowering drugs compared with placebo (or no treatment) in hypertensive patients, complemented by trials of more versus less intense BP lowering, have shown that antihypertensive treatment can significantly reduce the incidence of fatal and nonfatal events associated with hypertension. A meta-analysis of all BP-lowering trials from 1966...